Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Current Medicinal Chemistry|February 7, 2003
Poly(ADP-ribose) polymerase inhibitorsGarry J Southan, Csaba SzabóJournal of the American Society of Nephrology : JASN|May 23, 2000
Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell miceMilitza Kiroycheva, Fayyaz Ahmed, Gillian M Anthony, et al.International Journal of Molecular Medicine|February 10, 2004
Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in strokeKatalin Komjáti, John G Mabley, László Virág, et al.Tetrahedron Letters|February 18, 2010
Synthesis of (R)-3,4-dihydro-2H-pyran-2-carboxaldehyde: application to the synthesis of potent adenosine A(2A) and A(3) receptor agonistPrakash G Jagtap, Zhiyu Chen, Karsten Koppetsch, et al.Journal of Periodontology|March 4, 2006
Inhibition of experimental gingivitis in beagle dogs with topical mercaptoalkylguanidinesDavid W Paquette, Adam Rosenberg, Zsolt Lohinai, et al.Molecular Medicine (Cambridge, Mass.)|December 13, 2002
Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitisJon G Mabley, Lucas Liaudet, Pál Pacher, et al.Mutation Research|April 6, 2004
Suppression of intestinal polyposis in Apcmin/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathwaysJon G Mabley, Pál Pacher, Peter Bai, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1)Prakash G Jagtap, Garry J Southan, Erkan Baloglu, et al.Shock (Augusta, Ga.)|January 29, 2009
The novel inosine analogue INO-2002 exerts an anti-inflammatory effect in a murine model of acute lung injuryJon G Mabley, Pal Pacher, Kanneganti G K Murthy, et al.The Journal of Endocrinology|June 20, 2008
The novel inosine analogue, INO-2002, protects against diabetes development in multiple low-dose streptozotocin and non-obese diabetic mouse models of type I diabetesJon G Mabley, Pal Pacher, Kanneganti G K Murthy, et al.Pageof 2